CDMO News
PHC and CCRM Partner to Develop New T-Cell Expansion Culture Processes for CGT
PHC Corporation has entered a strategic collaboration with CCRM, a leader in regenerative medicine and biomanufacturing, to develop improved primary T-cell expansion culture processes for cell and gene therapy (CGT). The partnership aims to accelerate the manufacturing of cell-based therapeutics
10 February 2025